WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer today announced that it will present multiple new analyses of the KERENDIA ® (finerenone) clinical trial program at the European Renal Association (ERA) 62nd Congress scientific sessions in Vienna, Austria, June 4-7, 2025. KERENDIA is currently approved to reduce the risk of cardiovascular death, hospitalization for heart failure (HF), non-fatal myocardial infarction (MI), sustained eGFR decline, and end-stage kidney disease in adult patients with chronic.

WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer today announced the launch of its Imaging Core Lab Services under the brand name Centafore. With over 25 years of experience supporting more than 200 clinical trials at Bayer and its arm's length companies globally, Centafore is now positioned as a distinct Imaging solution provider, offering tailored services for external customers to support their clinical trials and Software as a Medical Device (SaMD) development across diverse therapeutic areas and dev.

WHIPPANY, N.J.--(BUSINESS WIRE)--The latest data from studies across Bayer's oncology and women's health portfolios will be presented at the upcoming 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place in Chicago from May 30–June 3. These data underscore Bayer's commitment to advancing treatments across different stages of cancer and driving the development of healthcare treatments, including for prostate and lung cancer. This year's ASCO presence also underscores Bay.

May is Women's Health Month – Dr. Yesmean Wahdan Shares Important and Timely Tips to Help Women Prioritize Their Health at Every Life Stage May is Women's Health Month – Dr. Yesmean Wahdan Shares Important and Timely Tips to Help Women Prioritize Their Health at Every Life Stage

WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer U.S. Surveys Shed Further Light on the Diversity of Menopause Care Approaches and Menopause Symptom Experiences.

ST. LOUIS--(BUSINESS WIRE)--Corn rootworm remains one of the most damaging pests in U.S. corn production, causing an estimated $1 billion in losses each year. To help farmers get ahead of this underground threat, Bayer is launching its eighth year of The Watch, a farmer-first program that offers free tools, education and expert support to monitor corn rootworm pressure and make proactive management decisions. “Corn rootworm is a yield-robbing pest that attacks at every stage of its life cycle —.

DALLAS--(BUSINESS WIRE)--Attorneys representing thousands of cancer victims criticized Bayer today for what they describe as an attempt to pressure courts, lawmakers and the public by threatening to pull its popular Roundup weedkiller from the market amid ongoing litigation. Video of the plaintiffs' attorneys' reactions is available here. Speaking at Bayer's annual shareholders meeting, CEO Bill Anderson warned that continued lawsuits could make it financially unsustainable for the company to c.

MONHEIM, Germany--(BUSINESS WIRE)--Bayer announced today that Guru Ramamurthy will become the new Chief Financial Officer (CFO) for Bayer's Crop Science division. He will succeed Oliver Rittgen who has decided to pursue a career opportunity outside of Bayer after 25 years with the company. In his current role, Guru Ramamurthy is serving as CFO of Bayer US. The change will become effective as of July 1, 2025. With over 20 years of experience at Bayer, Ramamurthy brings extensive financial expert.

CAMBRIDGE, Mass.--(BUSINESS WIRE)--ConcertAI announced a multi-year agreement with Bayer to leverage ConcertAI's Translational360™ -- powered by Guardant Health liquid biopsy genomic data -- and AI SaaS solutions, which use artificial intelligence and machine learning (AI/ML)-derived insights to accelerate clinical development in precision oncology. The agreement will fully leverage ConcertAI's newly launched Translational360™, an integrated research-grade longitudinal clinical molecular databa.